Status:
COMPLETED
Alveolar Bone Dehiscence and Fenestration Following Accelerated Maxillary Canine Retraction
Lead Sponsor:
Tanta University
Conditions:
Fenestration
Dehiscence
Eligibility:
All Genders
16-22 years
Phase:
NA
Brief Summary
Alveolar bone loss and fenestration are the most prevalent bone defects that often result in root exposure, gingival recession, and potential treatment relapse or failure. These issues present complic...
Eligibility Criteria
Inclusion
- Age of the patients ranged from 16: 22 years old.
- Malocclusion that requires extraction of the maxillary first premolar and canine retraction (e.g. class I bimaxillary dentoalveolar protrusion and class II div 1 malocclusion).
- Maximum anchorage needed for the maxillary arch as a part of the orthodontic treatment plan.
- Good oral hygiene and periodontal condition.
Exclusion
- Medically compromised patients.
- Severe crowding in the maxillary arch.
- Chronic intake of NSAIDs or any medication that interfere with OTM.
- Previous orthodontic treatment.
Key Trial Info
Start Date :
May 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 7 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06500559
Start Date
May 1 2024
End Date
September 7 2025
Last Update
September 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta University
Tanta, Tanta, Egypt, 6624033